GlaxoSmithKline reports payments made to physicians for speaking and consulting beginning in the second quarter of 2009. In 2011, it began reporting research payments in a separate report. In the fourth quarter of 2012, the company expanded its disclosure reports to include meals, travel and other value.
GlaxoSmithKline's 2013 U.S. sales: $12.8 billion. Source: IMS Health.
See all GlaxoSmithKline payments, or visit GlaxoSmithKline's transparency page.
Notable drugs
- Advair (asthma, COPD, chronic bronchitis, emphysema)
- Lovaza (high triglyceride levels)
- Flovent (asthma and COPD)
- Avodart (prostate enlargement)
- Ventolin (asthma, bronchospasms, reversible obstructive airway disease)
- Coreg (chronic heart failure, heart attack, hypertension)
- Imigran/Imitrex (migraine, cluster headaches)
- Valtrex (herpes, cold sores)
- Treximet (migraine)
- Votrient (renal cancer, soft-tissue sarcoma)
- Benlysta (lupus)
Payment Reports
2009 April to Dec.
|
Avg. Quarterly |
Total |
Speaking |
$15,431,934 |
$46,295,802 |
Consulting |
$1,456,866 |
$4,370,597 |
|
$16,888,800 |
$50,666,399 |
2010 Jan. to Dec.
|
Avg. Quarterly |
Total |
Speaking |
$13,188,948 |
$52,755,793 |
Consulting |
$1,004,756 |
$4,019,024 |
|
$14,193,704 |
$56,774,817 |
2011 Jan. to Dec.
|
Avg. Quarterly |
Total |
Speaking |
$6,017,673 |
$24,070,691 |
Consulting |
$1,071,322 |
$4,285,289 |
|
$7,088,995 |
$28,355,980 |
2011 Jan. to Dec. Research
|
Avg. Quarterly |
Total |
Research |
$23,141,271 |
$92,565,086 |
|
$23,141,271 |
$92,565,086 |
2012 Jan. to Sept.
|
Avg. Quarterly |
Total |
Speaking |
$2,540,690 |
$7,622,069 |
Consulting |
$862,118 |
$2,586,355 |
Adjustment |
-$1,400 |
-$4,200 |
|
$3,401,408 |
$10,204,224 |
2012 Jan. to Dec. Research
|
Avg. Quarterly |
Total |
Research |
$21,114,124 |
$84,456,496 |
|
$21,114,124 |
$84,456,496 |
2012 Oct. to Dec.
|
Avg. Quarterly |
Total |
Speaking |
$1,641,019 |
$1,641,019 |
Meals |
$694,871 |
$694,871 |
Consulting |
$617,745 |
$617,745 |
Travel |
$337,794 |
$337,794 |
Other |
$1,000 |
$1,000 |
|
$3,292,429 |
$3,292,429 |
2013 Jan. to Dec.
|
Avg. Quarterly |
Total |
Speaking |
$1,360,317 |
$5,441,266 |
Consulting |
$951,648 |
$3,806,593 |
Meals |
$863,825 |
$3,455,300 |
Travel |
$368,689 |
$1,474,755 |
Other |
$106,485 |
$425,942 |
Adjustment |
-$11,164 |
-$44,657 |
|
$3,639,800 |
$14,559,200 |
2013 Jan. to Dec. Research
|
Avg. Quarterly |
Total |
Research |
$24,266,715 |
$97,066,861 |
|
$24,266,715 |
$97,066,861 |